CVE-2026-87281 json
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core).
published last mo. modified last mo. also EUVD-2026-79933
- cvss
- 3.2
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.2%
- EPSS 0.2% chance of exploitation in 30 days, percentile 5%
- public exploits
- 0
- none known
Summary
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). The supported version that is affected is 7.2.16. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle VM VirtualBox accessible data. CVSS 3.1 Base Score 3.2 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:L/I:N/A:N).
Is CVE-2026-87281 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerCISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- last mo.
Exploit prediction
0.16% chance of exploitation in the next 30 days, higher than 5% of all scored CVEs (FIRST EPSS, 2026-11-11).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 3.2 | CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:L/I:N/A:N |
Affected products
- Oracle Corporation Oracle VM VirtualBox
Classification
- Weakness
-
- CWE-284 Improper Access Control
References
-
oracle.com
/security-alerts/cspusep2026.html
vendor-advisory
Sources
- CVE List CVE-2026-87281
- NVD CVE-2026-87281
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.